• / Free eNewsletters & Magazine
  • / My Account
Home>Phosphagenics' A$19.3 million Capital Raising

Phosphagenics' A$19.3 million Capital Raising

3party Content

Fri, 11 Jul 2014

- Includes A$3 million Share Purchase Plan- Upcoming opioid pain patch trials fully fundedMELBOURNE, Australia, July 11, 2014 /PRNewswire/ -- Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), today announced that it has raised A$19.3 million via a placement of A$16.3
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.